Regulus Therapeutics

About:

Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.

Website: http://www.regulusrx.com

Twitter/X: RegulusRx

Top Investors: RA Capital Management, New Enterprise Associates, Deep Track Capital, Federated Hermes, Vivo Capital

Description:

Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression. It was founded in 2007 and is headquartered in Carlsbad, California.